Global burden of HIV, viral hepatitis, and tuberculosis in prisoners and detainees

K Dolan, AL Wirtz, B Moazen, M Ndeffo-Mbah… - The Lancet, 2016 - thelancet.com
The prison setting presents not only challenges, but also opportunities, for the prevention
and treatment of HIV, viral hepatitis, and tuberculosis. We did a comprehensive literature …

Public health and international drug policy

J Csete, A Kamarulzaman, M Kazatchkine, F Altice… - The Lancet, 2016 - thelancet.com
Executive summary In September, 2015, the member states of the UN endorsed Sustainable
Development Goals (SDGs) for 2030, which aspire to human-rights-centred approaches to …

[图书][B] WHO guidelines on hepatitis B and C testing

World Health Organization - 2017 - apps.who.int
Web Annexes Page 1 Page | i GUIDELINES ON HEPATITIS B AND C TESTING February 2017
GUIDELINES ANNEXES Page 2 Page | ii WHO guidelines on hepatitis B and C testing ISBN …

Needle syringe programmes and opioid substitution therapy for preventing hepatitis C transmission in people who inject drugs

L Platt, S Minozzi, J Reed, P Vickerman… - Cochrane Database …, 2017 - cochranelibrary.com
Needle syringe programmes and opioid substitution therapy for preventing hepatitis C
transmission in people who inject drugs - Platt, L - 2017 | Cochrane Library Skip to Content …

The perfect storm: incarceration and the high-risk environment perpetuating transmission of HIV, hepatitis C virus, and tuberculosis in Eastern Europe and Central Asia

FL Altice, L Azbel, J Stone, E Brooks-Pollock… - The Lancet, 2016 - thelancet.com
Despite global reductions in HIV incidence and mortality, the 15 UNAIDS-designated
countries of Eastern Europe and Central Asia (EECA) that gained independence from the …

[PDF][PDF] Hepatitis C virus treatment for prevention among people who inject drugs: modeling treatment scale‐up in the age of direct‐acting antivirals

NK Martin, P Vickerman, J Grebely, M Hellard… - …, 2013 - Wiley Online Library
Substantial reductions in hepatitis C virus (HCV) prevalence among people who inject drugs
(PWID) cannot be achieved by harm reduction interventions such as needle exchange and …

Hepatitis C virus infection epidemiology among people who inject drugs in Europe: a systematic review of data for scaling up treatment and prevention

L Wiessing, M Ferri, B Grady, M Kantzanou, I Sperle… - PloS one, 2014 - journals.plos.org
Background People who inject drugs (PWID) are a key population affected by hepatitis C
virus (HCV). Treatment options are improving and may enhance prevention; however …

Diagnostic accuracy of serological diagnosis of hepatitis C and B using dried blood spot samples (DBS): two systematic reviews and meta-analyses

B Lange, J Cohn, T Roberts, J Camp, J Chauffour… - BMC infectious …, 2017 - Springer
Background Dried blood spots (DBS) are a convenient tool to enable diagnostic testing for
viral diseases due to transport, handling and logistical advantages over conventional …

Management of acute HCV infection in the era of direct-acting antiviral therapy

M Martinello, B Hajarizadeh, J Grebely… - Nature reviews …, 2018 - nature.com
The management of acute HCV infection has not been standardized following the
availability of direct-acting antiviral agents (DAAs) for chronic HCV infection, and substantial …

Modelling the impact of incarceration and prison‐based hepatitis C virus (HCV) treatment on HCV transmission among people who inject drugs in Scotland

J Stone, NK Martin, M Hickman, SJ Hutchinson… - …, 2017 - Wiley Online Library
Abstract Background and Aims People who inject drugs (PWID) experience high
incarceration rates, and previous incarceration is associated with elevated hepatitis C virus …